Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Nasonex Nasal Spray cleared for marketing in U.S.

Oct. 6, 1997

FDA clears Serevent Diskus

Oct. 3, 1997

Schering AG prepares new rolipram derivatives

Oct. 2, 1997

Dyax issued U.S. patent for novel elastase inhibitors

Oct. 2, 1997

Antileukotriene effects described for ebastine

Oct. 1, 1997

Peptidoleukotrienes and TxA2 both implicated in cough variant asthma

Oct. 1, 1997

Protective effects of Bayer's LTD4 antagonist demonstrated in asthmatic subjects

Oct. 1, 1997

Inhibitors of sCD23 production developed at SmithKline Beecham

Sep. 30, 1997

Zeneca describes SAR for new asthma therapy in development

Sep. 29, 1997

Arris reports data from phase IIa asthma trial

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...